SignalXSignalX

ARCT Arcturus Therapeutics Holdings Inc.

8-K Current Report
Filed: March 3, 2026
Health Care
Pharmaceutical Preparations
Arcturus Therapeutics Holdings Inc. Overview

Arcturus Therapeutics Holdings Inc. (ARCT) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q-period earnings results disclosed via press release exhibit — refer to Exhibit for actual financial figures
  • • Pipeline highlights flagged: ARCT-032 (respiratory) Phase 2 study sizing/timing, ARCT-810 (OTC disorder) regulatory alignment updates
+3 more insights

Get deeper insights on Arcturus Therapeutics Holdings Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.